SURPRISE, Ariz., Oct. 15, 2026 – (ACN Newswire) – SenesTech, Inc. (NASDAQ: SNESthe leader in rodent contraception and sustainable rodent population management, today revealed initial income results for the 3rd quarter of 2026. The Company prepares to launch its conclusive 3rd quarter monetary outcomes the week of November 9, 2026.
Initial 3rd quarter 2026 earnings was around$1.1 million, representing roughly 40%development compared to the 2nd quarter of 2026 and around 55%development compared to the 3rd quarter of 2025. It was likewise the Company’s very first quarter at or above the$1 million profits limit, an essential turning point.
The Company anticipates its conclusive 3rd quarter monetary outcomes to show ongoing momentum in e-commerce, consisting of greater membership income, which is broadening the repeating part of SenesTech’s income base, in addition to increasing traction in B2B.
“Our initial 3rd quarter income marks an essential turning point for SenesTechreaching the $1 million limit for the very first time and setting a 2nd successive quarterly record,” stated Michael Edell, Chief Executive Officer of SenesTech. “This is another quarter showing development on the strategies and methods we have actually formerly revealed, and our complete 3rd quarter monetary outcomes are anticipated to show that development throughout the industrial design we have actually been developing. E-commerce continues to scale as a manageable, data-driven acquisition engine, our vertical-focused B2B company is acquiring traction, and greater membership income is broadening our repeating income base and enhancing the quality and presence of profits.”
“We still have work to do, however our company believe this is a clear indicator that we are on the best course. We continue to lay the structure for a much bigger business in the future by working to broaden e-commerce and B2B considerably in an economical way. With a lot of the financial investments and shift expenses sustained previously in the year significantly behind us, combined with strong income development and enhanced system economics, we anticipate continued, enhanced metrics moving forward,” Edell concluded.
The initial 3rd quarter 2026 profits provided in this release is unaudited, initial and based on modification, and stays based on conclusion of the Company’s quarter-end closing treatments.
About SenesTech
SenesTech is the leader in rodent contraception and sustainable rodent population management, with an objective to support a much healthier environment through the accountable management of animal bug populations. The Company’s Evolve ® and ContraPest ® fertility control options, in addition to its evaluation and tracking services, target recreation to help in reducing rodent populations. SenesTech serves customer and expert markets with tested methods that can be utilized individually or as part of an incorporated insect management (IPM) program.
To learn more, go to https://senestech.com
Positive Statements
This news release consists of “positive declarations” within the significance of Section 27A of the Securities Act of 1933, as changed, and Section 21E of the Securities Exchange Act of 1934, as modified, which are planned to be covered by the safe harbor arrangements of the Private Securities Litigation Reform Act of 1995. These consist of declarations relating to the Company’s anticipated 3rd quarter 2026 profits, prepared for momentum in e-commerce and increasing traction in B2B, anticipated development throughout the Company’s industrial design, and prepared for continued, enhanced metrics moving forward. Words such as “expect,” “think,” “price quote,” “anticipate,” “mean,” “may,” “strategy,” “job,” “should,” “will” and comparable expressions are planned to determine positive declarations, although not all positive declarations consist of these words. Positive declarations are based upon present expectations and presumptions and go through dangers and unpredictabilities that might trigger real outcomes to vary materially from those revealed or indicated. These dangers consist of the threat that the Company might not understand the advantages anticipated from its e-commerce, B2B and membership techniques, or succeed in commercialization of its items, recognize enough market approval of its items, or take advantage of market chances and speed up development; the dangers of developing a totally brand-new item classification, consisting of the time, cost and unpredictability of developing market awareness and client approval; the threat that the Company might not have the ability to develop and scale an expert B2B sales company and to carry out a vertical-market technique; threats connected to the Company’s monetary efficiency, including its capability to money operations and possibly utilizing money sometimes and in methods aside from as prepared; and threats connected to regulative approval and guideline of the Company’s items. These and other threats are explained more totally in the Company’s filings with the Securities and Exchange Commission, consisting of under “Risk Factors” in its Annual Report on Form 10-K for the ended Dec. 31, 2025, and subsequent Quarterly Reports on Form 10-Q. Readers are warned not to put excessive dependence on these positive declarations, which speak just since the date of this release. Other than as needed by law, SenesTech carries out no responsibility to upgrade or modify any positive declaration.
Contacts:
Financier: Robert Blum, Lytham Partners, LLC, 602-889-9700,
Business: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143
Subject: Earnings
Source: SenesTech
Sectors: Daily News, Funds & & Equities, Cosmetics, Spec.Chem
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2026 ACN Newswire. All rights booked. A department of Asia Corporate News Network.
Discover more from PMN S.P.O.R.T.S - A PRIME MEDIA NETWORK BRAND
Subscribe to get the latest posts sent to your email.
